| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |